Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For LHYFE.PA
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio 0.00 4.29 4.29
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -51.29 4.03 8.27
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value -0.09 2.14 2.14
Cash -0.09 2.39 2.39
Capex -121.84 -0.71 -0.32
Free Cash Flow -126.25 -0.96 -0.43
Revenue 99.81 0.02 < 0.005
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin 3510.17 -16.03 0.44
Operating Margin -0.30 -19.12 -19.07
ROA -100.00 -0.09 -0.04
ROE -100.00 -0.17 -0.09
ROIC -111.97 -0.12 -0.06
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of LHYFE.PA is permitted for members.
5 Growth
The "Growth Entry" for the Focus of LHYFE.PA is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of LHYFE.PA is permitted for members.